Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹21,327 Cr
Revenue (TTM)
₹2,170 Cr
Net Profit (TTM)
₹333 Cr
ROE
11 %
ROCE
15.5 %
P/E Ratio
64.1
P/B Ratio
9
Industry P/E
--
EV/EBITDA
32.4
Div. Yield
0 %
Debt to Equity
0.1
Book Value
₹111.9
EPS
₹16.2
Face value
1
Shares outstanding
211,768,134
CFO
₹1,112.96 Cr
EBITDA
₹1,755.59 Cr
Net Profit
₹604.69 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sai Life Sciences
| 11.1 | 7.1 | 15.1 | 44.4 | -- | -- | -- |
|
BSE Healthcare
| -4.0 | -3.8 | -4.0 | 3.0 | 24.6 | 15.5 | 10.6 |
|
Company
|
2025
|
|---|---|
|
Sai Life Sciences
| 19.8 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sai Life Sciences
|
1,008.8 | 21,327.2 | 2,169.9 | 332.9 | 20.9 | 15.4 | 64.1 | 9.0 |
| 160.3 | 2,514.0 | 2,796.8 | 118.8 | 8.1 | 2.3 | 21.2 | 0.4 | |
| 28.4 | 8.7 | 0.5 | 0.0 | 8.3 | -1.1 | -- | 2.2 | |
| 445.7 | 10,713.4 | 3,262.7 | 439.0 | 15.3 | 16 | 24.4 | 3.6 | |
| 52.6 | 187.4 | 133.8 | -0.3 | -0.7 | -0.6 | -- | 1.9 | |
| 161.4 | 7,309.5 | 2,803.3 | 361.8 | 15.5 | 14 | 20.3 | 2.6 | |
| 21.4 | 635.7 | 1,450.4 | 47.9 | 6.6 | 10.1 | 14.2 | 1.4 | |
| 4,217.7 | 9,700.2 | 878.4 | 240.1 | 33.8 | 73.3 | 40.4 | 25.3 | |
| 38.1 | 564.1 | 0.0 | 1.6 | -- | -0.5 | 350.6 | 21.0 | |
| 24.7 | 54.8 | 51.4 | 4.5 | 22.0 | 5.2 | 12.1 | 0.6 |
Sai Life Sciences IPO analysis
5 min read•By Abhinav Goel
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The... company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India. Read more
Incorporated
1999
Chairman
Kanumuri Ranga Raju
Managing Director
Krishnam Raju Kanumuri
Headquarters
Hyderabad, Telangana
Website
Looking for more details about Sai Life Sciences Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Sai Life Sciences Ltd is ₹1,008.80 (NSE) and ₹1,007.10 (BSE) as of 19-Mar-2026 IST. Sai Life Sciences Ltd has given a return of 44.4% in the last 1 years.
The P/E ratio of Sai Life Sciences Ltd is 64.06 times as on 19-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
93.36
|
7.48
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Sai Life Sciences Ltd are Rs 1,084.00 and Rs 636.10 as of 19-Mar-2026.
Sai Life Sciences Ltd has a market capitalisation of ₹ 21,327 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Sai Life Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-5.05
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.